Robert M. Jotte, MD, Ph.D.

Provider Biography

Dr. Robert Jotte is a board-certified medical oncologist who sees all types of cancer and hematology patients. He practices evidence-based medicine and follows National Comprehensive Cancer Network (NCCN) guidelines. He treats patients in their community with cutting-edge targeted cancer treatments such as oral targeted therapy, immunotherapy, hormone therapy, as well as chemotherapy. He participates in global and national clinical trials, where he serves as both a local and national principal investigator. He has advanced sub-specialty expertise in treating lung cancer and head and neck cancer patients.

Dr. Jotte serves on the executive committee of the nationally renowned Sarah Cannon Research Institute (SCRI), the research arm of Rocky Mountain Cancer Centers, and is chair of the SCRI Lung Cancer Committee, where he oversees clinical research protocols for over 2,500 physicians. In addition, Dr. Jotte serves as principal investigator for many multi-phase trials and drug development studies.

SCRI has participated in the development of 29 of 36 FDA-approved cancer therapies for adults in 2023 and had over 4,500 registered patients participate in clinical trials.